• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
352.65 -5 (-1.29%)
  • As on 17 Jun 2025 (EOD)
  • Today’s Low

    349.85
  • Today’s High

    364.65
  • Open

    355.00
  • Perv Close

    357.25
  • 52W Low

    291.00
  • 52W High

    404.70

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    42,339.16

  • Div & Yield %

    0.35

  • Book Value(₹)

    95.98

  • Debt-Equity Ratio

    -1.29

  • AGM Date

    17-Jun-2025

  • EPS

    0.41

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    42,339.16

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    600.30

  • BV (₹)

    96.00

  • Sales( ₹ in Cr.)

    2,242.60

  • NP (in Cr.)

    49.23

  • NP Var(%)

    -54.0

  • Div%

    25.0

  • CPS (₹)

    1.50

  • EPS (₹)

    0.40

  • Traded Value (₹ in Lakhs)

    42,897.44

  • 52 Week High

    404.70

  • 52 Week Low

    291.00

  • Price BSE

    357.0

  • Price NSE

    357.00

  • Market Capital( in Cr.)

    42,897.44

  • P/C Ratio

    242.10

  • P/E Ratio

    870.60

  • Price Vs.BV

    0.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40 1,785.70
Other Income 207.50 3,134.20 187.20 150.20 366.00 422.00
Stock Adjustments 99.10 -3.20 105.80 -36.70 31.40 69.10
Total Income 2,433.90 5,123.90 2,031.20 2,141.90 2,385.80 2,276.80
EXPENDITURE :            
Raw Materials 1,033.80 981.00 914.00 761.60 859.10 857.60
Power and Fuel Cost 215.30 279.20 231.00 186.00 193.30 152.40
Employee Cost 452.30 433.80 367.70 390.20 344.80 289.10
Other Manufacturing Expenses 155.40 127.10 130.50 147.00 118.30 104.30
Selling and Administration Expenses 135.00 112.20 106.70 128.40 208.40 222.40
Miscellaneous Expenses -28.10 32.90 33.00 66.00 9.90 18.70
Employee Benefit Expenses 452.30 433.80 367.70 390.20 344.80 289.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,963.70 1,966.20 1,782.90 1,679.20 1,733.80 1,644.50
Operating Profit 470.20 3,157.70 248.30 462.70 652.00 632.30
Interest 198.80 69.60 0.40 0.40 1.20 2.60
Gross Profit 271.40 3,088.10 247.90 462.30 650.80 629.70
Depreciation 121.10 116.90 108.20 103.50 98.00 92.30
Profit Before Tax 150.30 2,971.20 139.70 358.80 552.80 537.40
Current Tax 15.10 132.70 60.70 73.50 104.40 54.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 15.90 -9.90 -7.10 4.80 7.50 -9.90
Reported Net Profit 119.30 2,848.40 86.10 280.50 440.90 492.70
Extraordinary Items 13.41 2,861.73 2.92 3.00 136.27 166.64
Adjusted Net Profit 105.89 -13.33 83.18 277.50 304.63 326.06
Adjustment below Net Profit 30.70 29.40 -59.40 30.40 22.60 -51.80
P & L Balance brought forward 9,950.60 7,132.80 7,106.10 6,795.20 6,391.80 6,020.60
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 180.10 60.00 0.00 0.00 60.10 69.40
P & L Balance carried down 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20 6,392.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 30.00 10.00 0.00 0.00 20.00
Dividend Per Share(Rs) 0.50 1.50 0.50 0.00 0.00 1.00
Earnings Per Share-Unit Curr 0.99 23.72 0.72 2.34 3.67 8.21
Earnings Per Share(Adj)-Unit Curr 0.99 23.72 0.72 2.34 3.67 4.11
Book Value 90.88 90.91 67.40 65.88 62.80 118.58
Book Value(Adj)-Unit Curr 90.88 90.91 67.40 65.88 62.80 59.29

Shareholding Pattern

  • Promoter Group

    60.64%

  • Public Share Holding

    39.15%

  • Custodian

    0.21%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 19.76 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,231,042 6,231,042.00 6,231,042 6,231,042
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,442,206 20.28 243,442,206 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 40.36 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 40.36 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,200 0.00 1,200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 68,000,552 5.66 68,000,552 246
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 78,595,952 6.55 78,595,952 17
Mutual Funds / UTI 105,267,671 8.77 105,267,671 30
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,927,139 0.41 4,927,139 11
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 256,792,514 21.39 256,792,514 305
2] Non Institution
Bodies Corporate 17,529,028 1.46 17,529,028 1,630
Clearing Members 4,778 0.00 4,778 8
Directors of their Relatives 7,320,441 0.61 7,320,441 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 12,979,034 1.08 12,626,524 9,011
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 4,965,546 0.41 4,965,366 6,632
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 67,639,121 5.63 67,544,141 257
Individuals holding nominal share capital up to Rs. 1 lakh 96,009,055 8.00 95,997,373 406,428
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,002,468 0.08 1,002,468 14
Others 5,796,917 0.48 5,796,917 4
Sub Total 213,246,388 17.76 212,787,036 423,987
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2,536,922 0.21 2,536,922 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2,536,922 0.21 2,536,922 1
Grand Total ( A + B + C ) 1,200,600,000 100.00 1,200,140,648 424,297

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013
  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    SIDDHARTH MITTAL

  • Company Secretary

    Mayank Verma

  • Auditor

    BSR & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 352.55 2,320.30 2,127.30 69.54 2.61
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92